166 related articles for article (PubMed ID: 9761232)
21. Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin.
Mollet A; Meier S; Grabler V; Gilg S; Scharrer E; Lutz TA
Peptides; 2003 Jan; 24(1):91-8. PubMed ID: 12576089
[TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complex.
Cooper MS; Reeve JR; Abdalla MO; Moyer L; Raboin SJ; Green GM; Sayegh AI
Brain Res; 2008 Apr; 1205():27-35. PubMed ID: 18346716
[TBL] [Abstract][Full Text] [Related]
23. Effects of amylin and salmon calcitonin on feeding and drinking behavior in pygmy goats.
Del Prete E; Schade B; Riediger T; Lutz TA; Scharrer E
Physiol Behav; 2002 Apr; 75(4):593-9. PubMed ID: 12062324
[TBL] [Abstract][Full Text] [Related]
24. Different influence of CGRP (8-37), an amylin and CGRP antagonist, on the anorectic effects of cholecystokinin and bombesin in diabetic and normal rats.
Lutz TA; Pieber TR; Walzer B; Del Prete E; Scharrer E
Peptides; 1997; 18(5):643-9. PubMed ID: 9213356
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic amylin as a centrally acting satiating hormone.
Lutz TA
Curr Drug Targets; 2005 Mar; 6(2):181-9. PubMed ID: 15777188
[TBL] [Abstract][Full Text] [Related]
26. Amylin and gastrointestinal activity.
Guidobono F
Gen Pharmacol; 1998 Aug; 31(2):173-7. PubMed ID: 9688456
[TBL] [Abstract][Full Text] [Related]
27. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD
Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527
[TBL] [Abstract][Full Text] [Related]
28. The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway.
Frommelt L; Lembke V; Hofmann T; Goebel-Stengel M; Mönnikes H; Wiedenmann B; Klapp BF; Stengel A; Kobelt P
Peptides; 2013 Jan; 39():111-8. PubMed ID: 23200724
[TBL] [Abstract][Full Text] [Related]
29. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
[TBL] [Abstract][Full Text] [Related]
30. Behaviorally specific inhibition of sham feeding by amylin.
Asarian L; Eckel LA; Geary N
Peptides; 1998; 19(10):1711-8. PubMed ID: 9880076
[TBL] [Abstract][Full Text] [Related]
31. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.
Lo CM; Zhang DM; Pearson K; Ma L; Sun W; Sakai RR; Davidson WS; Liu M; Raybould HE; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1490-4. PubMed ID: 17634201
[TBL] [Abstract][Full Text] [Related]
32. Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin.
Lutz TA; Del Prete E; Scharrer E
Peptides; 1995; 16(3):457-62. PubMed ID: 7651899
[TBL] [Abstract][Full Text] [Related]
33. Effect of anorexinergic peptides, cholecystokinin (CCK) and cocaine and amphetamine regulated transcript (CART) peptide, on the activity of neurons in hypothalamic structures of C57Bl/6 mice involved in the food intake regulation.
Pirnik Z; Maixnerová J; Matysková R; Koutová D; Zelezná B; Maletínská L; Kiss A
Peptides; 2010 Jan; 31(1):139-44. PubMed ID: 19818819
[TBL] [Abstract][Full Text] [Related]
34. Gastroprotection and control of food intake by leptin. Comparison with cholecystokinin and prostaglandins.
Konturek PC; Konturek SJ; Brzozowski T; Hahn EG
J Physiol Pharmacol; 1999 Mar; 50(1):39-48. PubMed ID: 10210153
[TBL] [Abstract][Full Text] [Related]
35. Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration.
Lo CM; Xu M; Yang Q; Zheng S; Carey KM; Tubb MR; Davidson WS; Liu M; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R43-50. PubMed ID: 19020287
[TBL] [Abstract][Full Text] [Related]
36. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
[TBL] [Abstract][Full Text] [Related]
37. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats.
Glatzle J; Raybould HE; Kueper MA; Reeve JR; Zittel TT
Nutr Neurosci; 2008 Apr; 11(2):69-74. PubMed ID: 18510806
[TBL] [Abstract][Full Text] [Related]
38. Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.
Mack CM; Smith PA; Athanacio JR; Xu K; Wilson JK; Reynolds JM; Jodka CM; Lu MG; Parkes DG
Diabetes Obes Metab; 2011 Dec; 13(12):1105-13. PubMed ID: 21733060
[TBL] [Abstract][Full Text] [Related]
39. Gut peptides in the control of food intake.
Moran TH
Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S7-10. PubMed ID: 19363513
[TBL] [Abstract][Full Text] [Related]
40. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
